Acute Responses to Walking, Stair Climbing, and Functional Circuit Exercise
4 de setembro de 2026 atualizado por: Ramazan Bayer, Malatya Turgut Ozal University
Acute Metabolic, Respiratory, and Neuromotor Responses to Walking, Stair Climbing, and Functional Circuit Exercise in Sedentary Individuals: A Heart Rate-Controlled Randomized Crossover Study
This study evaluated the acute physiological responses to three different exercise modalities in sedentary young men. Participants completed walking, stair climbing, and functional circuit exercise sessions in a randomized crossover design. Each exercise session lasted 20 minutes and was performed at a target intensity of 50% heart rate reserve (±5 beats/min), with at least 72 hours between sessions.
The study compared acute respiratory, metabolic, and neuromotor responses to the three exercise modalities. Pulmonary function was assessed using spirometry, blood lactate concentration was measured using capillary blood samples, and countermovement jump performance was assessed as an indicator of neuromuscular performance. Heart rate was continuously monitored during each exercise session.
Visão geral do estudo
Status
Concluído
Condições
Tipo de estudo
Intervencional
Inscrição (Real)
30
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Malatya
-
Malatya, Malatya, Turquia (Türkiye), 44100
- Malatya Turgut Ozal University
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Sim
Descrição
Inclusion Criteria:
- Male sex.
- Aged 18-30 years.
- Classified as sedentary/insufficiently active according to the study eligibility criteria.
- Able to safely complete the exercise protocols and study assessments.
- Provided voluntary informed consent.
Exclusion Criteria:
- Current cigarette or electronic cigarette use.
- Known cardiovascular, respiratory, or metabolic disease.
- Regular medication use that could affect physiological responses to exercise.
- Acute infection within the previous 2 weeks.
- Musculoskeletal conditions that could interfere with safe participation in the exercise protocols.
- Any condition requiring medical evaluation before exercise participation.
- Inability to obtain acceptable baseline spirometry measurements according to the study procedures.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: WP-SP-FCP Sequence
Participants completed the Walking Protocol first, followed by the Stair Climbing Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
|
|
Experimental: WP-FCP-SP Sequence
Participants completed the Walking Protocol first, followed by the Functional Circuit Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
|
|
Experimental: SP-WP-FCP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Walking Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
|
|
Experimental: SP-FCP-WP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Functional Circuit Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
|
|
Experimental: FCP-WP-SP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Walking Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
|
|
Experimental: FCP-SP-WP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Stair Climbing Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Forced Expiratory Volume in One Second (FEV1)
Prazo: Baseline and 5 minutes after each exercise session
|
Forced expiratory volume in one second (FEV1) was measured by spirometry before and 5 minutes after each exercise condition.
The primary outcome was the change in FEV1 (ΔFEV1), calculated as post-exercise FEV1 minus pre-exercise FEV1 and expressed in liters (L).
Measurements were obtained following standardized spirometry procedures.
|
Baseline and 5 minutes after each exercise session
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Forced Vital Capacity (FVC)
Prazo: Baseline and 5 minutes after each exercise session
|
Forced vital capacity (FVC) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FVC (ΔFVC), calculated as post-exercise FVC minus pre-exercise FVC and expressed in liters (L).
|
Baseline and 5 minutes after each exercise session
|
|
Change in FEV1/FVC Ratio
Prazo: Baseline and 5 minutes after each exercise session
|
The FEV1/FVC ratio was assessed by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FEV1/FVC ratio (ΔFEV1/FVC), calculated as the post-exercise value minus the pre-exercise value.
|
Baseline and 5 minutes after each exercise session
|
|
Change in Peak Expiratory Flow (PEF)
Prazo: Baseline and 5 minutes after each exercise session
|
Peak expiratory flow (PEF) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in PEF (ΔPEF), calculated as the post-exercise PEF minus the pre-exercise PEF and expressed in liters per second (L/s).
|
Baseline and 5 minutes after each exercise session
|
|
Change in Blood Lactate Concentration
Prazo: Baseline and 3 minutes after each exercise session
|
Capillary blood lactate concentration was measured before exercise and 3 minutes after each exercise condition.
The outcome was the change in blood lactate concentration (ΔLactate), calculated as the post-exercise value minus the pre-exercise value and expressed in millimoles per liter (mmol/L).
|
Baseline and 3 minutes after each exercise session
|
|
Change in Countermovement Jump Height (CMJ)
Prazo: Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
Countermovement jump (CMJ) height was assessed before and after each exercise condition.
The outcome was the change in CMJ height (ΔCMJ), calculated as the post-exercise value minus the pre-exercise value and expressed in centimeters (cm).
|
Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
|
Mean Heart Rate During Exercise
Prazo: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Mean heart rate was calculated across the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Maximum Heart Rate During Exercise
Prazo: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Maximum heart rate was defined as the highest heart rate recorded during the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Time Spent in the Target Heart Rate Range
Prazo: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
The outcome was the percentage of exercise time during which heart rate remained within ±5 beats/min of the individualized target heart rate corresponding to 50% heart rate reserve (HRR)
|
During each 20-minute exercise session
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
22 de junho de 2026
Conclusão Primária (Real)
5 de agosto de 2026
Conclusão do estudo (Real)
5 de agosto de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
1 de setembro de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
4 de setembro de 2026
Primeira postagem (Real)
8 de setembro de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
8 de setembro de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
4 de setembro de 2026
Última verificação
1 de setembro de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026/205
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
Individual participant data are not planned to be shared because no data-sharing plan was established as part of the original study protocol.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .